Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma

BACKGROUND: Anthracycline-containing regimens, namely cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) or CHOEP (CHOP + etoposide), represent the current standard of care for patients with newly diagnosed peripheral T-cell lymphomas (PTCLs), although responses are unsatisfactory. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Magni, Martina, Biancon, Giulia, Rizzitano, Sara, Cavanè, Alessandra, Paolizzi, Chiara, Dugo, Matteo, Corradini, Paolo, Carniti, Cristiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889385/
https://www.ncbi.nlm.nih.gov/pubmed/31474759
http://dx.doi.org/10.1038/s41416-019-0557-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889385/
https://www.ncbi.nlm.nih.gov/pubmed/31474759
http://dx.doi.org/10.1038/s41416-019-0557-8

Ejemplares similares